{"cik":"0001300781","entityName":"DH Enchantment, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-18","val":831310013,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q4I"}]}}},"us-gaap":{"AccountsPayableAndOtherAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Other Accrued Liabilities, Current","description":"Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2021-03-31","val":1783,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":51950,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"AccumulatedOtherComprehensiveIncomeLossNetOfTax":{"label":"Accumulated Other Comprehensive Income (Loss), Net of Tax","description":"Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.","units":{"USD":[{"end":"2021-03-31","val":-10,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":251,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2021-03-31","val":74360,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":76909,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2021-03-31","val":74360,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":76909,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q1I"},{"end":"2020-09-30","val":13484,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3I"},{"end":"2021-03-31","val":72768,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":75514,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":13484,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":2746,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2021-03-31","val":0.001,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":0.001,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2021-03-31","val":4400000000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":4400000000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2021-03-31","val":511309161,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":831310013,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2021-03-31","val":511309161,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":831310013,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2021-03-31","val":511309,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":831310,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ComprehensiveIncomeNetOfTax":{"label":"Comprehensive Income (Loss), Net of Tax, Attributable to Parent","description":"Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-8598,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-29,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":-260440,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-169739,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"CostOfRevenue":{"label":"Cost of Revenue","description":"The aggregate cost of goods produced and sold and services rendered during the reporting period.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":122724,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":34495,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"CurrentIncomeTaxExpenseBenefit":{"label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"DeferredIncomeTaxExpenseBenefit":{"label":"Deferred Income Tax Expense (Benefit)","description":"Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"DeferredOtherTaxExpenseBenefit":{"label":"Deferred Other Tax Expense (Benefit)","description":"Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":1206,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":33627,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"DeferredTaxAssetsNet":{"label":"Deferred Tax Assets, Net of Valuation Allowance","description":"Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"DeferredTaxAssetsOperatingLossCarryforwards":{"label":"Deferred Tax Assets, Operating Loss Carryforwards","description":"Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":33627,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"DeferredTaxAssetsValuationAllowance":{"label":"Deferred Tax Assets, Valuation Allowance","description":"Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":33627,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"DueToAffiliateCurrent":{"label":"Due to Affiliate, Current","description":"Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-03-31","val":63887,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":66100,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"DueToOfficersOrStockholdersCurrent":{"label":"Due to Officers or Stockholders, Current","description":"Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":133557,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-04-01","end":"2020-09-30","val":-0.09,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":{"label":"Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent","description":"Percentage of domestic federal statutory tax rate applicable to pretax income (loss).","units":{"pure":[{"start":"2020-04-01","end":"2020-09-30","val":0.165,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0.165,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"EffectOfExchangeRateOnCashAndCashEquivalents":{"label":"Effect of Exchange Rate on Cash and Cash Equivalents","description":"Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":12,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":261,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":30,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":80383,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":42035,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"GrossProfit":{"label":"Gross Profit","description":"Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":23161,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":11578,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":-203799,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"IncomeTaxesPaidNet":{"label":"Income Taxes Paid, Net","description":"The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"IncomeTaxReconciliationDeductions":{"label":"Effective Income Tax Rate Reconciliation, Deduction, Amount","description":"Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":215,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate":{"label":"Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount","description":"The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-1421,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":-33627,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"IncreaseDecreaseInAccountsAndOtherReceivables":{"label":"Increase (Decrease) in Accounts and Other Receivables","description":"The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":-197,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities","description":"Amount of increase (decrease) in accrued expenses, and obligations classified as other.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":50167,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"InterestExpenseRelatedParty":{"label":"Interest Expense, Related Party","description":"Amount of interest expense incurred on a debt or other obligation to related party.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":2636,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":2015,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"InterestPaid":{"label":"Interest Paid, Including Capitalized Interest, Operating and Investing Activities","description":"Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2021-03-31","val":65670,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":328659,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2021-03-31","val":74360,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":76909,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2021-03-31","val":65670,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":328659,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"LiabilityForUncertainTaxPositionsCurrent":{"label":"Liability for Uncertainty in Income Taxes, Current","description":"Amount recognized for uncertainty in income taxes classified as current.","units":{"USD":[{"end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3I"},{"end":"2021-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":22082,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":212822,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":-210337,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-30,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-06-30","val":-90708,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"},{"start":"2021-04-01","end":"2021-09-30","val":-260701,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-169993,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"NotesPayableRelatedPartiesClassifiedCurrent":{"label":"Notes Payable, Related Parties, Current","description":"The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":77052,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":30,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":281271,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":179601,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-30,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":-258110,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-168023,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax":{"label":"OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax","description":"Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.","units":{"USD":[{"start":"2020-04-01","end":"2020-06-30","val":11,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":1,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-06-30","val":7,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":254,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax":{"label":"Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax","description":"Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":-12,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-1,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":-261,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-254,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OtherReceivablesNetCurrent":{"label":"Other Receivables, Net, Current","description":"Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.","units":{"USD":[{"end":"2021-03-31","val":1592,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":1395,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfLongTermDebt":{"label":"Proceeds from Issuance of Long-term Debt","description":"The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-04-01","end":"2021-09-30","val":77052,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"}]}},"ProfessionalFees":{"label":"Professional Fees","description":"A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":200888,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":137566,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-04-01","end":"2020-06-30","val":-8580,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2"},{"start":"2020-04-01","end":"2020-09-30","val":-8610,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-30,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":-260701,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-169993,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2021-03-31","val":-510549,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-09-30","val":-1089651,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"Revenues":{"label":"Revenues","description":"Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":145885,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":46073,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-06-30","val":-8680,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-8698,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3I"},{"end":"2021-03-31","val":8690,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-82011,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-251750,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"UnrealizedGainOnForeignCurrencyDerivativesBeforeTax":{"label":"Unrealized Gain on Foreign Currency Derivatives, before Tax","description":"Amount of unrealized gain related to the increase in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.","units":{"USD":[{"start":"2020-04-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":45,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":45,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-04-01","end":"2020-09-30","val":100000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":100000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":672183692,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":831309587,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-04-01","end":"2020-09-30","val":100000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":100000,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-09-30","val":672183692,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":831309587,"accn":"0001683168-21-005887","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}}}}}